Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Antagonizing the Ghrelin Receptor on Total-body Glucose Metabolism in Obesity

NCT06254365 is registered in ClinicalTrials.gov with University Hospital, Gentofte, Copenhagen as lead sponsor.

NCT NCT06254365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06254365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Antagonizing the Ghrelin Receptor on Total-body Glucose Metabolism in Obesity
Lead sponsor
University Hospital, Gentofte, Copenhagen
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 21, 2024
Completion date
September 30, 2025
Enrollment
9 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity